Baloxavir marboxil: a novel cap-dependent endonuclease (CEN) inhibitor for the treatment of acute uncomplicated influenza.
págs. 359-366
Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura.
Pascale Poullin, Charléric Bornet, Agnès Veyradier, Paul Coppo
págs. 367-376
Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension.
Lorenzo Ferro Desideri, Carlo Alberto Cutolo, Fabio Barra, Simone Ferrero, Carlo Enrico Traverso
págs. 377-384
American Society of Clinical Oncology (ASCO): 55th Annual Meeting (May 31-June 4, 2019 – Chicago, Illinois, USA)
págs. 407-416
págs. 417-418
© 2001-2024 Fundación Dialnet · Todos los derechos reservados